Cost-Effectiveness of Real-World Administration of Concomitant Viscum album L. Therapy for the Treatment of Stage IV Pancreatic Cancer

Figure 3

Sensitivity analyses of the outcome cost per month OS from the hospital’s perspective. Incremental cost-effectiveness plane showing random 1000-fold resampled estimates (bootstrap analysis) of incremental costs and benefits (age-adjusted mean cost per patient in combination with age-adjusted mean month OS) of using treatment for mPC versus C treatment.